Eurekabio
Latest round
- Series B
Last raised
- Feb 2024
Total raised
- $42M
Investors
- 11
About Eurekabio
Founded in 2014 and based in Shenzhen, China, Eurekabio is a biotech company that focuses on providing cell and gene therapy services. The company has branches in cities such as Shanghai and Hong Kong. It has partnered with companies such as GenScript Biotech and Terumo Bister. The company's main products include CellSep®? PRO fully enclosed automated cell processing system, EuLV®? system and EuBioX system, etc. CellSep®?, and achieves gradient separation of different components under the action of centrifugation.
Who invested in Eurekabio
11 investors across 4 rounds
See all investors in Eurekabio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Eurekabio
Who invested in Eurekabio?
Eurekabio has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eurekabio raised?
Eurekabio has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Eurekabio last raise money?
Eurekabio's most recent round on record is a Series B, in Feb 2024.
What does Eurekabio do?
Founded in 2014 and based in Shenzhen, China, Eurekabio is a biotech company that focuses on providing cell and gene therapy services.
Where is Eurekabio headquartered?
Eurekabio is headquartered in Shenzhen, China.
Which VCs invest in companies like Eurekabio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Eurekabio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Eurekabio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.